52
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Preclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeys

, , , , , , , , , , , , & show all
Pages 6689-6698 | Published online: 28 Oct 2015

References

  • SullivanDCMolecular imaging in oncologyAnn Oncol200617suppl 10x287x29217018740
  • XiLZhouGGaoNPhotoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobeAnn Surg Oncol20142151602160924554061
  • JamesMLGambhirSSA molecular imaging primer: modalities, imaging agents, and applicationsPhysiol Rev201292289796522535898
  • EstelrichJSanchez-MartinMJBusquetsMANanoparticles in magnetic resonance imaging: from simple to dual contrast agentsInt J Nanomedicine2015101727174125834422
  • ChenFEhlerdingEBCaiWTheranostic nanoparticlesJ Nucl Med201455121919192225413134
  • ChenZMengHXingGAcute toxicological effects of copper nanoparticles in vivoToxicol Lett2006163210912016289865
  • WhiteheadAStallardNOpportunities for reduction in acute toxicity testing via improved designAltern Lab Anim200432suppl 2738015601231
  • KumariMRajakSSinghSPRepeated oral dose toxicity of iron oxide nanoparticles: biochemical and histopathological alterations in different tissues of ratsJ Nanosci Nanotechnol20121232149215922755032
  • LiuHMaLZhaoJBiochemical toxicity of nanoanatase TiO2 particles in miceBiol Trace Elem Res20091291–317018019066734
  • SayesCMWahiRKurianPACorrelating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cellsToxicol Sci200692117418516613837
  • PetrelliFBorgonovoKBarniSTargeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxelExpert Opin Pharmacother20101181413143220446855
  • LeonardRCWilliamsSTulpuleALevineAMOliverosSImproving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)Breast200918421822419656681
  • PlougMØstergaardSGårdsvollHPeptide-derived antagonists of the urokinase receptor. Affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasationBiochemistry20014040121571216811580291
  • BaldiniESorrentiSD’ArmientoEDi MatteoFMCataniaAUlisseSThe urokinase plasminogen activating system in thyroid cancer: clinical implicationsG Chir2012331030531023095556
  • MekkawyAHMorrisDLPourgholamiMHUrokinase plasminogen activator system as a potential target for cancer therapyFuture Oncol2009591487149919903074
  • RomerJNielsenBSPlougMThe urokinase receptor as a potential target in cancer therapyCurr Pharm Des200410192359237615279614
  • YangLSajjaHKCaoZuPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detectionTheranostics20134110611824396518
  • YangLPengXHWangYAReceptor-targeted nanoparticles for in vivo imaging of breast cancerClin Cancer Res200915144722473219584158
  • LiuDOverbeyDWatkinsonLGiblinMFSynthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR)Bioconjug Chem200920588889419354275
  • WangFEric KnabeWLiLDesign, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptorBioorg Med Chem201220154760477322771232
  • LiRZhengKHuPA novel tumor targeting drug carrier for optical imaging and therapyTheranostics20144664265924723985
  • LeeGYQianWPWangLTheranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancerACS Nano2013732078208923402593
  • PattersonTATwaddleNCRoeggeCSCallicottRJFisherJWDoergeDRConcurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeysToxicol Appl Pharmacol20132671414823261975
  • Vom SaalFSVandeVoortCATaylorJAWelshonsWVToutainPLHuntPABisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: relevance for human exposuresReprod Toxicol20144510511624582107
  • FisherJWTwaddleNCVanlandinghamMDoergeDRPharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humansToxicol Appl Pharmacol2011257112213621920375
  • YangPHanPHouJElectrocardiographic characterization of rhesus monkey model of ischemic myocardial infarction induced by left anterior descending artery ligationCardiovasc Toxicol201111436537221792668
  • TaylorJAVom SaalFSWelshonsWVSimilarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposureEnviron Health Perspect2011119442243020855240
  • ChenHWangLYuQAnti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancerInt J Nanomedicine201383781379424124366
  • BulteJWKraitchmanDLIron oxide MR contrast agents for molecular and cellular imagingNMR Biomed200417748449915526347
  • ThorekDLChenAKCzuprynaJTsourkasASuperparamagnetic iron oxide nanoparticle probes for molecular imagingAnn Biomed Eng2006341233816496086
  • VeisehOGunnJWZhangMDesign and fabrication of magnetic nanoparticles for targeted drug delivery and imagingAdv Drug Deliv Rev201062328430419909778
  • JunYWLeeJHCheonJChemical design of nanoparticle probes for high-performance magnetic resonance imagingAngew Chem Int Ed Engl200847285122513518574805
  • HuangJZhongXWangLYangLMaoHImproving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticlesTheranostics2012218610222272222
  • XieJChenKHuangJPET/NIRF/MRI triple functional iron oxide nanoparticlesBiomaterials201031113016302220092887
  • AlarifiSAliDAl-DoaissAAAliBAAhmedMAl-KhedhairyAAHistologic and apoptotic changes induced by titanium dioxide nano-particles in the livers of ratsInt J Nanomedicine201383937394324143098
  • CawelloWFichtnerABoekensHBraunMInfluence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotineEur J Drug Metab Pharmacokinet201439315516324052490
  • Concepcion NavarroMPilar MontillaMMartinAJimenezJPilar UtrillaMFree radical scavenger and antihepatotoxic activity of Rosmarinus tomentosusPlanta Med19935943123148372145
  • KimTYKimDJAcute-on-chronic liver failureClin Mol Hepatol201319434935924459638
  • Zamora NavaLEAguirre ValadezJChavez-TapiaNCTorreAAcute-on-chronic liver failure: a reviewTher Clin Risk Manag20141029530324790454
  • KharePSonaneMPandeyRAliSGuptaKCSatishAAdverse effects of TiO2 and ZnO nanoparticles in soil nematode, Caenorhabditis elegansJ Biomed Nanotechnol20117111611721485831
  • MaitiSNanotoxicity of gold and iron nanoparticlesJ Biomed Nanotechnol2011716521485805
  • YouJZhouJZhouMPharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheresPart Fibre Toxicol2014112624886070
  • SarhanOMHusseinRMEffects of intraperitoneally injected silver nanoparticles on histological structures and blood parameters in the albino ratInt J Nanomedicine201491505151724711700
  • ZhengJCLeiNHeQCPEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of alpha-momorcharin in vivoImmunopharmacol Immunotoxicol201234586687322439816
  • EsmaeillouMMoharamnejadMHsankhaniRTehraniAAMaadiHToxicity of ZnO nanoparticles in healthy adult miceEnviron Toxicol Pharmacol2013351677123262039
  • YangLMaoHCaoZMolecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticlesGastroenterology2009136515141525.e219208341